CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome
Sang Kyun Sohn, Joon Ho Moon, In Hee Lee, Jae Sook Ahn, Hyeoung Joon Kim, Joo Seop Chung, Ho Jin Shin, Sung Woo Park, Won Sik Lee, Sang Min Lee, Hawk Kim, Ho Sup Lee, Yang Soo Kim, Yoon Young Cho, Sung Hwa Bae, Ji Hyun Lee, Sung Hyun Kim, Ik Chan Song, Ji Hyun Kwon, Yoo Jin Lee
Korean J Intern Med. 2018;33(6):1194-1202.   Published online 2017 December 15    DOI: https://doi.org/10.3904/kjim.2016.426

Excel Download

No Benefit of Hypomethylating Agents Compared to Supportive Care for Higher Risk Myelodysplastic Syndrome by IPSS-R
Leukemia Research. 2017;55:S65   Crossref logo
Link1 Link2

No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome
The Korean Journal of Internal Medicine. 2018;33(6):1194-1202   Crossref logo
Link1 Link2 Link3

Hypomethylating agents in combination with histone deacetylase inhibitors in higher risk myelodysplastic syndromes: Is there a light at the end of the tunnel?
Cancer. 2017;123(6):911-914   Crossref logo
Link1 Link2

Treatment of Higher-Risk Myelodysplastic Syndromes After Failure of Hypomethylating Agents
Clinical Lymphoma Myeloma and Leukemia. 2015;15:S56-S59   Crossref logo
Link1 Link2

Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na
Leukemia Research. 2012;36(1):98-103   Crossref logo
Link1 Link2

If All You Have Is a Hammer…: Transplantation for Myelodysplastic Syndrome after Hypomethylating Agents Fail
Biology of Blood and Marrow Transplantation. 2017;23(9):1413-1414   Crossref logo
Link1 Link2

Evidence for Selective Benefit of Sequential Treatment With Hypomethylating Agents in Patients With Myelodysplastic Syndrome
Clinical Lymphoma Myeloma and Leukemia. 2017;17(4):211-214   Crossref logo
Link1 Link2

PCN115 Patterns of Care in Patients With Myelodysplastic Syndromes Treated With Hypomethylating Agents
Value in Health. 2012;15(4):A228   Crossref logo
Link1 Link2

Treatment with Hypomethylating Agents (HMA)
Hematologic Malignancies. 2018;131-139   Crossref logo
Link1

Iron Chelation Therapy in Lower IPSS Risk Myelodysplastic Syndrome; Which Subtypes Benefit?
Leukemia Research. 2017;55:S165   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.